Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7312 p209
14 August 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacists facing sharp increase in Society fees

Increases in past five years

Society retention fees have increased steadily in the past five years with the exception of one sharp rise in 2002.

From 1999 to 2000, the fee was raised by 3 per cent and the increase was similar in 2001. This was followed by a major increase of 31 per cent from £142 in 2001 to £186 in 2002. Subsequent increases were 4.8 per cent in 2003 and 5 per cent in 2004. Reasons given for the 2002 hike in fees were to fund both constitutional change and new areas of professional and regulatory activity in order to meet the modernisation agenda (PJ, 11 August 2001, p209).

Pharmacists are facing a 25 per cent increase in next year’s annual retention fee for membership of the Royal Pharmaceutical Society.

The Society announced this week that, subject to Privy Council approval, it plans a retention fee increase of £51 next year. This will increase the levy from £205 this year to £256. The reasons for this are covered in the Society section (see p233). To summarise, it is because in recent years the level of the retention fee has not matched the growth in both regulatory and membership activities. As a result, the Society has had to depend on income from its publishing activities and the Society’s Council has agreed that this is not prudent because of risks in the marketplace.

The Society has also decided to simplify the fee structure so that there will only be two levels of fee compared with the current five. Pharmacists will either pay a practising rate or a non-practising rate, which it is envisaged will be one-third of the practising fee. The Society says that the current fees for those aged over 60 years and those retired due to ill health neither cover the cost of the administration involved in collecting the fee and maintaining the register, nor the cost of providing The Journal. It adds that having only two levels will also bring all practising pharmacists into one category, which will make regulation more transparent.

The fees compare favourably with those paid by doctors and dentists, but less well with fees paid by nurses. Most health professions pay separate fees: one for regulation and one for professional representation. Doctors, for example, have to be registered with the General Medical Council (the regulatory body) and have the option of being a member of the British Medical Association. Almost 80 per cent of UK doctors are BMA members. The annual GMC registration fee is £290 this year, and has been at this level since 2002. A decision on next year’s fee has yet to be made. On top of this, full membership of the BMA costs £335 this year, and the proposed rate for next year is £360.

Nurses are regulated by the Nursing and Midwifery Council to which they pay a three-yearly retention fee of £129. Annual membership of the Royal College of Nursing, which is the representative body, is £158.

The General Dental Council is the regulatory body for dentists. Its annual retention fee this year is £388. The fee was sharply increased — by 160 per cent — from £135 in 2002 to £350 in 2003 (PJ, 20 April 2002, p521). Next year’s increase is proposed at just 2 per cent, subject to Privy Council approval. The GDC says that the 2003 fee hike was largely due to its modernisation programme, including work around the registration of dental technicians, and also to process an increasing number of complaints. Membership of the British Dental Association, the dentists’ representative body, costs £396 this year. Next year’s fee is not yet known.

However, the BDA is currently facing financial crisis. This week, it confirmed that its overspend for 2002/03 was £760,000 with a projected deficit of £1.5m in 2003/04. Its finance director has resigned. A recovery plan has been put in place and it hopes to return to financial surplus by October.

Back to Top


©The Pharmaceutical Journal